Shenzhen Chipscreen Biosciences Co (688321) — Capital Reinvestment Ratio
Shenzhen Chipscreen Biosciences Co (688321) has a Capital Reinvestment Ratio of 27.48x as of September 2025, meaning it reinvests 27% of its operating cash flow (CN¥2.25 Million) in capital expenditures (CN¥61.73 Million). See how leveraged is Shenzhen Chipscreen Biosciences Co's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Chipscreen Biosciences Co Capital Reinvestment Ratio (2016–2024)
This chart tracks Shenzhen Chipscreen Biosciences Co's Capital Reinvestment Ratio across 7 annual periods. Check Shenzhen Chipscreen Biosciences Co (688321) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co from 2016 to 2024. For live market cap and broader valuation context, see market value of Shenzhen Chipscreen Biosciences Co.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.53x | CN¥76.13 Million | CN¥268.49 Million | ▼ -61.8% |
| 2022 | 9.24x | CN¥43.30 Million | CN¥400.17 Million | ▲ +299.8% |
| 2021 | 2.31x | CN¥124.78 Million | CN¥288.46 Million | ▼ -35.6% |
| 2020 | 3.59x | CN¥93.62 Million | CN¥336.27 Million | ▼ -41.9% |
| 2018 | 6.18x | CN¥22.78 Million | CN¥140.74 Million | ▼ -87.3% |
| 2017 | 48.65x | CN¥2.73 Million | CN¥132.82 Million | ▲ +4318.2% |
| 2016 | 1.10x | CN¥59.77 Million | CN¥65.81 Million | — |